Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable and microsatellite instability-high locally advanced rectal cancer.
Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable and microsatellite instability-high locally advanced rectal cancer.
复制标题
DOI：
10.1200/jco.2020.38.15_suppl.4100
复制
发表时间：
2020-05
影响因子：
45.3
通讯作者：
S. Yuki;H. Bando;Y. Tsukada;K. Inamori;Y. Komatsu;S. Homma;M. Uemura;Takeshi Kato;D. Kotani;S. Fukuoka;N. Nakamura;M. Fukui;M. Wakabayashi;M. Kojima;Y. Togashi;A. Sato;H. Nishikawa;Masaaki Ito;T. Yoshino
中科院分区：
文献类型：
--
作者：
S. Yuki;H. Bando;Y. Tsukada;K. Inamori;Y. Komatsu;S. Homma;M. Uemura;Takeshi Kato;D. Kotani;S. Fukuoka;N. Nakamura;M. Fukui;M. Wakabayashi;M. Kojima;Y. Togashi;A. Sato;H. Nishikawa;Masaaki Ito;T. Yoshino
4100背景：局部进展期直肠癌（LARC）患者的标准治疗是放化疗（CRT）后进行根治性手术（S）。序贯使用抗PD-1抗体后...
4100Background: Chemoradiotherapy (CRT) followed by radical surgery (S) is standard therapy for patients (pts) with locally advanced rectal cancer (LARC). Sequential use of an anti-PD-1 antibody af...